You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Compact Turbo-Rankin Energy Conversion System

    SBC: CREARE LLC            Topic: 8211

    Creare is developing a miniature power system for NOA weather monitoring stations in remote locations. This system can provide electric power continuously from naturally occurring temperature differences that exist between ambient air and water in environments such as the Arctic Ocean and the Great Lakes. Generating power directly from these temperature difference uses the atmosphere and ocean/lat ...

    SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration
  2. Multimodal Acoustic Tool for Inline Pipe Inspection

    SBC: CREARE LLC            Topic: 180PH1

    The United States has a vast network of pipelines used for fuel transport. This infrastructure, installed in 1950–1970, is one of the largest in the world. Yet poor/missing records of the materials used, combined with the overall age and associated environmental degradation effects, often results in unsafe operation. Current non-destructive inspection techniques are only capable of detecting mat ...

    SBIR Phase II 2019 Department of Transportation
  3. Discovery of Parasite-Derived Tolerogenic Adjuvants

    SBC: CELDARA MEDICAL, LLC            Topic: NIAID

    Our goal is to identify novel parasite derived immunomodulatory tolerogenic adjuvants that can suppress pro inflammatory and autoimmune disease statessuch as typediabeteswhich has no disease modifying treatmentParasitic helminths establish chronic infection by modulating host innate and adaptive immune responsesdown regulating T effector cellsstimulating Thand or inducing regulatory B and T cellsS ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. AUTOMATED PLATE TRANSPORT SYSTEM

    SBC: CREARE LLC            Topic: NIDA

    High throughput screeningHTShas emerged as a leading method of drug discovery and development in the pharmaceutical industryacademiaand at the NIH National Center for Advancing Translational SciencesNCATSHTS relies on the ability to rapidly screen tens of thousands of compounds to identify the most promising drugs and their dose response curvesHTS isof necessityhighly automated and demands mechani ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  5. TOPIC 343: NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS

    SBC: CREARE LLC            Topic: NCI

    Cognitive decline is a major quality of life concern for many cancer survivorsThevarious available treatments affect individuals differentlyand research has unfortunately provided little guidance on how specific treatments impact neurocognitive functionTo help researchers fill this information gap and ultimately provide guidance to doctors and patientsa neuropsychological assessment system that is ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  6. A novel antibody therapy for Sin Nombre virus infection

    SBC: CELDARA MEDICAL, LLC            Topic: NIAID

    Project Summary Rodent-borne viral outbreaks are increasing in both frequency and impact. Hantaviruses are transmitted through the excreta of infected rodents and, when aerosolized, infect humans. In the Americas, hantavirus infection leads to hantavirus cardiopulmonary syndrome (HCPS), a devastating condition that features rapid onset of pulmonary edema, respiratory failure and cardiogenic shock. ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Cellular Immunotherapy for Systemic Sclerosis

    SBC: CELDARA MEDICAL, LLC            Topic: NIAMS

    Project Summary Systemic sclerosis (SSc) is a systemic autoimmune disease that results in widespread fibrosis of the skin and internal organs, vascular dropout and autoantibody formation. SSc has the highest case fatality rate of any systemic autoimmune disease and there remain no FDA-approved therapies. Our data and that of others indicate that the innate immune system is the major driver of fibr ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Development/Commercialization of a Sensing Device to Detect Vaping

    SBC: FRESHAIR SENSOR, LLC            Topic: NIDA

    Development Commercialization of a Sensing Device to Detect Vaping Summary The use of e cigarettes or vaping has been steadily increasing since its introductionWhile potentially a tool to wean cigarette smokers from combustible tobaccoone consequence of the introduction of these devices has been the adoption of vaping by adolescentsWhile companies that offer vaping instruments for sale note that t ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Intraoperative Stereovision for Surgical Guidance

    SBC: InSight Surgical Technologies LLC            Topic: 393

    PROJECT SUMMARY ABSTRACTInSight Surgical TechnologiesLLCis a newly formed start up founded by senior members of a long standing NIH funded research effort to develop intraoperative image updating that maintains accurate image correspondence with the surgical field throughout a procedureThe effort has led to research innovations that have generated an intellectual propertyIPportfolio ofissued andpe ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Antimicrobial peptides to combat MDR ESKAPE pathogens

    SBC: CELDARA MEDICAL, LLC            Topic: R

    Project Summary Bacterial resistance has reached alarming levels in the US and other parts of the world in the past decadeThe increase in bacterial infection with drug resistantDRpathogens are resulting in increasing healthcare costs and a decline in positive clinical outcomesSerious infections leading to sepsis remain a public health concernIn the United States aloneapproximatelypatients develop ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government